Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Nature Biotechnology
|
June 5, 2003
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Svetlana O Doronina, Brian E Toki, Michael Y Torgov, et al.
Blood
|
April 26, 2003
cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity
Joseph A Francisco, Charles G Cerveny, Damon L Meyer, et al.
Molecular Cancer Therapeutics
|
March 6, 2016
Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates
Patrick J Burke, Joseph Z Hamilton, Thomas A Pires, et al.
Bioconjugate Chemistry
|
May 24, 2024
Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation
Philip N Moquist, Xinqun Zhang, Chris I Leiske, et al.
Molecular Cancer Therapeutics
|
October 29, 2025
Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models
David R Gruber, Elizabeth J Cummins, Weiping Zeng, et al.
Molecular Cancer Therapeutics
|
September 23, 2018
Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug Conjugates
Christopher S Neumann, Kathleen C Olivas, Martha E Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2006
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma
Kam Fai Tse, Michael Jeffers, Vincent A Pollack, et al.
Blood
|
June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
May S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Molecular Cancer Therapeutics
|
December 4, 2020
Development of Novel Antibody-Camptothecin Conjugates
Ryan D Lyski, Lauren B Bou, Uland Y Lau, et al.
Cancer Research
|
February 21, 2006
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates
Che-Leung Law, Kristine A Gordon, Brian E Toki, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Nature Biotechnology
|
June 5, 2003
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Svetlana O Doronina, Brian E Toki, Michael Y Torgov, et al.
Blood
|
April 26, 2003
cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity
Joseph A Francisco, Charles G Cerveny, Damon L Meyer, et al.
Molecular Cancer Therapeutics
|
March 6, 2016
Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates
Patrick J Burke, Joseph Z Hamilton, Thomas A Pires, et al.
Bioconjugate Chemistry
|
May 24, 2024
Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation
Philip N Moquist, Xinqun Zhang, Chris I Leiske, et al.
Molecular Cancer Therapeutics
|
October 29, 2025
Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models
David R Gruber, Elizabeth J Cummins, Weiping Zeng, et al.
Molecular Cancer Therapeutics
|
September 23, 2018
Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug Conjugates
Christopher S Neumann, Kathleen C Olivas, Martha E Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2006
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma
Kam Fai Tse, Michael Jeffers, Vincent A Pollack, et al.
Blood
|
June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
May S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Molecular Cancer Therapeutics
|
December 4, 2020
Development of Novel Antibody-Camptothecin Conjugates
Ryan D Lyski, Lauren B Bou, Uland Y Lau, et al.
Cancer Research
|
February 21, 2006
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates
Che-Leung Law, Kristine A Gordon, Brian E Toki, et al.
Page
of 9